Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
Nobuyo Higashi‐Kuwata, Kohei Tsuji, Hironori Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

SERS-based microdevices for use as in vitro diagnostic biosensors
Sungwoon Lee, Hajun Dang, Joung‐Il Moon, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5394-5427
Closed Access | Times Cited: 53
Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
Girish Chandra, Durg Vijay Singh, Gopal Kumar Mahato, et al.
Chemical Papers (2023) Vol. 77, Iss. 8, pp. 4085-4106
Open Access | Times Cited: 48
Recent advances in point-of-care testing of COVID-19
Sungwoon Lee, Liyan Bi, Hao Chen, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8500-8530
Closed Access | Times Cited: 43
Using a crumpled graphene field-effect transistor for ultrasensitive SARS-CoV-2 detection via its papain-like protease
Shicai Xu, Meng Tian, Chonghui Li, et al.
Chemical Engineering Journal (2025) Vol. 505, pp. 159386-159386
Closed Access | Times Cited: 3
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1339-1339
Open Access | Times Cited: 28
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 17
Thioamides in medicinal chemistry and as small molecule therapeutic agents
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116732-116732
Closed Access | Times Cited: 7
Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19
Yang Li, Si-Ming Lu, Jia-Long Wang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33179-e33179
Open Access | Times Cited: 6
Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13516-13529
Closed Access | Times Cited: 16
Recent Advances on SARS-CoV-2 Mpro Inhibitors: From Nirmatrelvir to Future Perspectives
Andrea Citarella, Alessandro Dimasi, Davide Moi, et al.
(2023)
Open Access | Times Cited: 14
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability
Shenghua Gao, Letian Song, Katharina Sylvester, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16426-16440
Closed Access | Times Cited: 14
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, et al.
European Journal of Medicinal Chemistry (2025), pp. 117603-117603
Open Access
Mutagenesis-Guided Target Identification Reveals the Protein-Binding Domain of Nsp14 in Coronaviruses as the Target of a Labdane-Oxindole Compound
Wei Shen Ho, Thinesshwary Yogarajah, Jasmaadiyah Binte Habib Mohameed, et al.
ACS Infectious Diseases (2025)
Closed Access
Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Native mass spectrometry for characterization of proteins binding with small molecules and application in drug discovery
Meng Cui, Yang Du
TrAC Trends in Analytical Chemistry (2024) Vol. 174, pp. 117701-117701
Closed Access | Times Cited: 3
Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs
Julian Breidenbach, Rabea Voget, Yaoyao Si, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8757-8790
Closed Access | Times Cited: 3
Covalent binding of withanolides to cysteines of protein targets
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Development of Acylhydrazone Linked Thiazoles as Non-Covalent Dual Inhibitors of SARS-CoV-2 Proteases
Vidya Jyothi Alli, Shubham Singh, Mounika Darna, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117509-117509
Closed Access
Structural and virologic mechanism of the emergence of resistance to M pro inhibitors in SARS-CoV-2
Shin-ichiro Hattori, Haydar Bulut, Hironori Hayashi, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 3
Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease
Wenjin Li, Xiaoyu Chang, Hang Zhou, et al.
Journal of Molecular Recognition (2024)
Closed Access | Times Cited: 1
Contrasting mechanistic susceptibilities of hematopoietic and endothelial stem-progenitor cells in respective pathogeneses of HIV-1 and SARS-CoV-2 infections
Prasad S Koka, Bharathi Ramdass
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Exploratory Studies on Amide Bond Replacement of a SARS-CoV-2 Main Protease Inhibitor Utilizing a Chloroalkene Dipeptide Isostere
Takuya Kobayakawa, Chika Azuma, Nobuyo Higashi‐Kuwata, et al.
Research Square (Research Square) (2024)
Open Access
MOLECULAR MODELLING AND THEORETICAL DESIGN OF NOVEL NIRMATRELVIR DERIVATIVES AS SARS-COV-2 ENTRY INHIBITORS
Mohammed Oday Ezzat
New Materials Compounds and Applications (2024) Vol. 8, Iss. 2, pp. 178-189
Open Access
Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication
David A. Davis, Ashwin Nair, Yana Astter, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Page 1 - Next Page

Scroll to top